FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anna Azvolinsky

Research Profile

Chemicals & Drugs

Disorders

Physiology

Living Beings

Saccharomyces cerevisiae

Procedures

Anatomy

Concepts & Ideas

S Phase

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anna Azvolinsky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna Azvolinsky
One size does not fit all: personalized immune therapies poised to take center stage.
Journal of the National Cancer Institute 2013;105(9):583-4.
2013: Anna Azvolinsky
Cancer vaccines: always a bridesmaid, never a bride?
Journal of the National Cancer Institute 2013;105(4):248-9.
2013: Anna Azvolinsky
Diagnostic lens turns to difficult-to-detect ovarian cancer.
Nature medicine 2013;19(2):117.
2012: Anna Azvolinsky
PARP inhibitors: targeting the right patients.
Journal of the National Cancer Institute 2012;104(24):1851-2.
2012: Anna Azvolinsky
Assessing cancer with a blood draw.
Journal of the National Cancer Institute 2012;104(23):1774-5.
2012: Anna Azvolinsky
Lack of BRCA testing approval creates snag for cancer trials.
Nature medicine 2012;18(9):1310.
2012: Anna Azvolinsky
Cancer stem cells: getting to the root of cancer.
Journal of the National Cancer Institute 2012;104(12):893-5.
2012: Anna Azvolinsky
Preserving fertility in cancer patients.
Journal of the National Cancer Institute 2012;104(10):724-5.
2012: Anna Azvolinsky
Companies hope for rare win with cancer stem cell therapies.
Nature medicine 2012;18(4):474.
2010: Daniele Fachinetti; Rodrigo Bermejo; Andrea Cocito; Simone Minardi; Yuki Katou; Yutaka Kanoh; Katsuhiko Shirahige; Anna Azvolinsky; Virginia A Zakian; Marco Foiani
Replication termination at eukaryotic chromosomes is mediated by Top2 and occurs at genomic loci containing pausing elements.
Molecular cell 2010;39(4):595-605.
2009: Anna Azvolinsky; Paul G Giresi; Jason Dillon Lieb; Virginia A Zakian
Highly transcribed RNA polymerase II genes are impediments to replication fork progression in Saccharomyces cerevisiae.
Molecular cell 2009;34(6):722-34.
2008: Nicolas Vidal; Anna Azvolinsky; Corinne Cruaud; S Blair Hedges
Origin of tropical American burrowing reptiles by transatlantic rafting.
Biology letters 2008;4(1):115-8.
2007: Diana Cozma; Duonan Yu; Suchita Hodawadekar; Anna Azvolinsky; Shannon M Grande; John W Tobias; Michele H Metzgar; Jennifer Paterson; Jan Erikson; Teresa Marafioti; John G Monroe; Michael L Atchison; Andrei Thomas-Tikhonenko
B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
The Journal of clinical investigation 2007;117(9):2602-10.
2006: Anna Azvolinsky; Stephen Dunaway; Jorge Z Torres; Jessica B Bessler; Virginia A Zakian
The S. cerevisiae Rrm3p DNA helicase moves with the replication fork and affects replication of all yeast chromosomes.
Genes & development 2006;20(22):3104-16.
2002: Severin Gudima; Jinhong Chang; Gloria Moraleda; Anna Azvolinsky; John Taylor
Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA.
Journal of virology 2002;76(8):3709-19.